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ORIGINAL ARTICLE

Visits to Rheumatologists for Arthritis: The Role of
Access to Primary Care Physicians, Geographic
Availability of Rheumatologists, and
Socioeconomic Status
ELIZABETH M. BADLEY,1 MAYILEE CANIZARES,2 ANNA C. GUNZ,3

AND

AILEEN M. DAVIS2

Objective. This multilevel study examines access to rheumatologists for all arthritis and inﬂammatory arthritis, taking
into account geographic availability of rheumatologists, access to primary care physicians (PCPs), and population
characteristics (e.g., socioeconomic status [SES]).
Methods. We analyzed data from the population (age >18 years) living in the 105 health planning areas in Ontario,
Canada on visits to physicians for arthritis and musculoskeletal disorders. Using data from a survey of rheumatologists
and Geographic Information System analysis, an index of geographic availability for rheumatologists was calculated,
incorporating distance between the population and rheumatologist locations and the number of hours per week of
rheumatologist care. Multilevel Poisson regression was used to examine factors associated with the rates of rheumatology
visits for inﬂammatory arthritis and all arthritis.
Results. Controlling for age and sex, the rheumatologist availability index was associated with visit rates for all arthritis,
but not inﬂammatory arthritis. Patients living in areas with low access to PCPs or low SES were less likely to have ofﬁce
visits to rheumatologists for all arthritis and inﬂammatory arthritis.
Conclusion. Besides potential deﬁciencies in rheumatology provision, there may be access barriers to rheumatology
services, particularly for populations with low access to PCPs or low SES. This is of special concern for patients with
inﬂammatory arthritis for whom rheumatologist care is necessary. In developing models of care for arthritis, this study
points to the need to pay attention to areas with low PCP resources and areas of low SES, as well as the location and
amount of rheumatology services available.

INTRODUCTION
Adequate patient access to rheumatologists is critical
given the importance of early treatment of rheumatoid
arthritis (RA) with disease-modifying antirheumatic drugs
(DMARDs) and biologic agents. There is a critical window of opportunity where aggressive intervention with
DMARDs has been shown to improve clinical outcomes,
functional status, and quality of life (1), as well as decrease
job loss and reduce sick leave (2). Furthermore, delays in
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initiating therapy have been associated with worse outcomes (3). As disease-modifying therapy is rarely initiated
by primary care physicians (PCPs) (4 –7), attention has
focused on the importance of timely access to rheumatologists, particularly for rheumatoid and other forms of inﬂammatory arthritis (8). However, a full appreciation of
access to rheumatologists for the treatment of inﬂammatory arthritis needs to be set within a wider context.
In health care systems such as in Canada, where with
universal health insurance PCPs have a gatekeeper role,
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Signiﬁcance & Innovations
●

Patients with inﬂammatory arthritis living in areas
of low socioeconomic status or with a low provision of primary care services were less likely to see
a rheumatologist.

●

Higher availability of rheumatologists was associated with higher visit rates to rheumatologists for
all arthritis, but not for inﬂammatory arthritis.

●

Patients with noninﬂammatory arthritis are likely
to be seen by rheumatologists only in those areas
where there is adequate availability of rheumatologists.

PCPs are usually the ﬁrst contact for patients with inﬂammatory arthritis. However, early diagnosis of these conditions by PCPs and subsequent referral to a rheumatologist
remains a challenge and a major contributor to delays in
initiation of disease-modifying therapy (3,9,10). Studies
have shown that PCPs may not feel conﬁdent about their
ability to diagnose arthritis, which may limit their willingness to initiate referral to rheumatologists or to manage RA
with DMARDs (4,5). In addition, shortages of rheumatologists and long waiting lists may act as barriers to referral
(11–13).
Strategies to promote timely access to rheumatologists
have focused on efforts to identify patients with early RA
in the community and on educational programs at the
primary care level to identify patients with potential inﬂammatory arthritis to promote referral and triage, as well
as on initiatives to prioritize referred patients to see a
rheumatologist (3,8). Less attention has been paid to the
question of availability and accessibility of rheumatology
services. There is some evidence that perceptions of low
availability of specialists and long travel distances may
deter referral (14,15). Regional variability in availability of
rheumatologists may be exacerbated by regional variations
in need, such as the age structure of the population. Indeed, this has been used for estimating need for rheumatologists in the US (11). Other factors associated with
potential need, but not usually considered, include socioeconomic status (SES), which is associated with access to
health care and to specialists in particular (16,17). Furthermore, individuals of low SES have a higher risk of developing RA, and RA is more prevalent in rural areas (18).
Understanding patterns of care for patients with inﬂammatory arthritis is important for targeting interventions
and improving access to care in the population. The purpose of this study was to examine the per capita rate of
visits to rheumatologists as an indicator of access to care
within health planning regions of Ontario, Canada for all
arthritis and inﬂammatory arthritis. The analyses considered access to PCPs, an index of geographic availability of
rheumatologists, and population characteristics, including
SES.
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MATERIALS AND METHODS
Setting and study design. The setting for this population-based, multilevel study is the 105 health planning
areas (administrative areas known as sub-Local Health Integration Networks) in Ontario, Canada. The Ontario
Health Insurance Plan (OHIP) provides universal coverage
to Ontarians for all medically necessary hospital and physician services with no copayments or other patient
charges. Access to specialists is by referral from other
physicians, usually PCPs. There are no restrictions on the
location and type of specialists to whom referral can be
made. The majority of physicians operate on a fee-forservice basis; a claim is submitted to the provincial health
insurance plan for each patient encounter. We have data
for all individuals age ⱖ18 years with musculoskeletal
disorders in Ontario, Canada who visited any type of physician, including rheumatologists, in the ﬁscal year 2007–
2008 (April 1, 2007 to March 31, 2008). This represents all
visits in the province (19,20).
Data sources and variables. The Registered Persons
Database was linked to the OHIP physician billing database and provided data, by health planning area, on the
number by age and sex of patients with at least 1 ofﬁce
visit to a physician for all arthritis (inﬂammatory arthritis,
osteoarthritis, soft-tissue disorders, traumatic arthritis, and
“other arthritis”), and for inﬂammatory arthritis (rheumatoid arthritis, Still’s disease, ankylosing spondylitis, disseminated lupus erythematosus, scleroderma, polyarteritis nodosa, and temporal arteritis) (20 –22). For a detailed
list of available codes related to arthritis, see Supplementary Table 1, available in the online version of this article
at http://onlinelibrary.wiley.com/doi/10.1002/acr.22413/
abstract. Data on the number of patients with ofﬁce visits
to PCPs with diagnostic codes relevant to musculoskeletal disorders were also extracted (20 –22). The Institute
of Clinical Evaluative Sciences Physician Database was
linked to the OHIP database to identify physician specialty
for each visit. Physicians were classiﬁed as rheumatologists, PCPs, or other physicians. All claims made by the
same physician on the same date for the same patient were
considered 1 visit.
Population characteristics. Statistics Canada 2006 Census data were used to calculate indicators of SES, age of
the population (proportion age ⱖ65 years), and proportion
of rural population for each health planning area. SES was
calculated by combining the median household income
with the proportion of the population with less than a high
school education. Both components were standardized
into a z score and combined into an overall score (23). Age
and SES indicators were categorized in quintiles to facilitate interpretation. Given the urban–rural distribution in
Ontario, the proportion of rural population was categorized as ⬍15%, 15– 49%, and ⱖ50%.
Access to PCPs. As no data were available on the volume of care provided by PCPs in each health planning
area, the rate of individuals visiting PCPs for musculoskeletal disorders was used as a proxy measure of access
within each health planning area. The measure was cate-
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gorized into quintiles for simplicity of presentation. Given
that patients with musculoskeletal disorders comprise a
high proportion of all patients seen by PCPs, this measure
likely reﬂects actual access to PCPs in this population
(20,21).
Index of geographic availability of rheumatologists.
Data on postal codes of all rheumatologist practice locations and the number of clinic hours per week at each
location were extracted from a 2007 survey of Ontario
rheumatologists (24). Practice locations were geo-coded
using Geographic Information System (GIS) software (25)
and assigned to a dissemination area (DA). DAs are the
smallest geographic units for which census data are available (there are 19,777 DAs in Ontario). A geographic availability index was derived for each health planning area
using a gravity model (26). In the ﬁrst step, working from
each DA population centroid, distance from each rheumatologist location to each DA population centroid was calculated using the Minkowski metric (27), which has been
found to be a good approximation to the road distance. A
sum of the clinical hours available from rheumatologists
weighted by the inverse of the squared distance from the
population to all rheumatologist locations within a reasonable distance (we used 50 km) was calculated (Figure 1
illustrates the spatial calculation of the index). The inverse

Badley et al

Table 1. Use of rheumatology services, access to
primary care physicians (PCPs), and rheumatologists’
availability across health planning areas (n ⴝ 105);
Ontario, ﬁscal year 2007–2008*
Median Min.–max.
Visits for all arthritis†
To rheumatologists
To all physicians‡
Visits for all inﬂammatory arthritis†
To rheumatologists
To all physicians
Access to PCPs†
Patients with visits for
musculoskeletal disorders
Availability of rheumatologists
Rheumatologists availability
index (weighted hours per
week per 100,000 population)
Distance to nearest
rheumatologist location, km
Percent population within 50
km of rheumatologists

13.4
130.4

5.3–26.0
60.7–218.5

6.9
11.5

1.8–14.8
3.3–30.6

250.4 140.3–558.7

3.1

0.0–521.1

44.7

1.0–584.0

75.0

0.0–100.0

* Min. ⫽ minimum; max. ⫽ maximum.
† Rates per 1,000 population.
‡ Includes rheumatologist, PCPs, and other types of physicians.

of the squared distance gives more weight to nearer locations, so the farther away the rheumatologist, the lower the
contribution to the overall availability for the population.
The contributions for each rheumatologist location were
combined and the index was expressed as the weighted
sum per 100,000 population. In a ﬁnal step, a weighted
index for each health planning area was calculated by
aggregation of the respective DA-level data to the relevant
health planning area. All spatial calculations were performed using ArcGIS 9.1 and SAS. Given the distribution
of the geographic availability index, for analytic purposes,
a 5-level variable was created with a category for zero
availability, and then quartiles for the remaining health
planning areas.
This study received ethical approval through the Institutional Research Board of Sunnybrook Health Sciences
Centre to access the health care utilization databases. Research ethics approval from the University Health Network was obtained for conducting the survey of rheumatologists.

Figure 1. Spatial representation of the calculations of the index
of geographic availability of rheumatologists. DA ⫽ dissemination
area with population centroid marked with a dot; R ⫽ location
where rheumatologist services are provided.

Statistical analysis. Multilevel Poisson regression was
used to examine factors associated with the rates of rheumatology visits for all arthritis and for inﬂammatory arthritis. The outcomes were modeled as age and sex strata
nested within each health planning area to account for
variation in rates at the individual level. Based on previous work, an age by sex interaction term was added to all
models to correct for the differential pattern in rates of
ofﬁce visits across sex and age groups (21). Random intercept models were used to allow the outcomes to vary
across health planning areas and the Poisson distribution
was used. Population counts for each stratum were added

Access to Rheumatologists
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Figure 2. Index of geographic availability of rheumatologists across health planning areas, Ontario, ﬁscal year 2007–
2008. Cities with medical schools are identiﬁed in the map: Thunder Bay, Sudbury (Northern Ontario School of
Medicine: opened in 2005, so was still in start-up mode at the time of the 2007 rheumatologist survey); Ottawa
(University of Ottawa Medical School); Kingston (School of Medicine Queen’s University); Toronto (University of
Toronto Medical School); Hamilton (Michael G. DeGroote School of Medicine, McMaster University); London
(Schulich School of Medicine & Dentistry, University of Western Ontario).

as an offset in all models. The estimates obtained from the
regression models compare the log of the rate of ofﬁce
visits by individual and area-level indicators: rheumatologist geographic availability, PCP access, SES, age of the
population, and proportion of rural population. Rate ratios
were calculated by exponentiating the regression coefﬁcients. We used a sequential approach to perform the
analyses. All models included individuals’ age and sex, an

age–sex interaction term, and area-level indicators. We
modeled ofﬁce visit rates to rheumatologists for all arthritis and for inﬂammatory arthritis separately, testing for
main effects as well as adjusted models. Analyses were
conducted in SAS using proc GLIMMIX. Rate ratios for the
ﬁxed effects (i.e., individual- and area-level indicators)
and 95% conﬁdence intervals from multilevel regression
models are presented.
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Table 2. Rate per 1,000 population for visits to all physicians and rheumatologists for all arthritis and inﬂammatory arthritis
by individual and area-level indicators; Ontario, ﬁscal year 2007–2008*
All physicians†

Individual-level indicators
Sex
Women
Men
Age groups, years
18–24
25–34
35–44
45–54
55–64
65–74
ⱖ75
Area-level indicators
Geographic availability of rheumatologists
None
Quartile I
Quartile II
Quartile III
Quartile IV (highest)
Access to PCP
Quintile I (lowest)
Quintile II
Quintile III
Quintile IV
Quintile V (highest)
SES
Quintile I (lowest)
Quintile II
Quintile III
Quintile IV
Quintile V (highest)
Proportion of population age ⱖ65 years
Quintile I (lowest)
Quintile II
Quintile III
Quintile IV
Quintile V (highest)
Proportion of rural population
⬍15%
15–50%
⬎50%

Rheumatologists

All
arthritis

Inﬂammatory
arthritis

All
arthritis

Inﬂammatory
arthritis

150.2
114.2

16.1
7.2

20.0
8.1

9.8
3.6

41.1
59.4
93.5
151.1
201.5
238.7
246.0

2.4
4.3
7.3
12.7
19.6
24.3
23.2

2.2
4.2
8.0
15.6
25.0
30.8
29.1

1.4
2.6
4.3
7.5
11.6
14.2
11.8

131.2
133.2
134.3
136.3
129.6

11.2
11.6
13.0
12.5
12.7

15.0
14.4
15.1
11.3
9.8

6.8
6.3
8.3
6.8
6.5

112.7
122.2
129.4
139.2
141.1

10.6
11.7
12.0
12.8
11.2

10.2
11.6
14.0
15.5
15.9

5.6
6.2
6.9
7.8
6.6

127.6
137.8
134.4
132.3
130.2

12.1
12.6
11.6
11.7
11.2

11.1
12.4
13.0
14.8
17.1

5.8
6.3
6.6
6.9
7.5

128.5
131.6
132.3
137.0
139.9

11.3
11.1
11.8
13.4
12.0

15.4
15.4
13.2
13.4
13.1

6.9
7.1
6.4
6.8
6.7

132.6
131.5
135.3

11.2
12.8
12.6

15.5
12.1
12.0

6.7
6.8
7.2

* PCP ⫽ primary care physician; SES ⫽ socioeconomic status.
† Includes rheumatologists, primary care physicians, and other types of physician.

Sensitivity analysis. Results are presented for the index
of geographic availability of rheumatologists calculated
using a distance of 50 km. An index calculated using
25-km, 75-km, and 100-km thresholds yielded similar
results.

RESULTS
In Ontario in the 2007–2008 ﬁscal year, the rate of visits to
all physicians for any kind of arthritis was 130.4 per 1,000
population and the rate of visits to rheumatologists was
13.4 per 1,000 population. This represents 10.3% of all

patients who made at least 1 visit to a physician for any
kind of arthritis. There was a wide variation (from 5.3 to
26.0 per 1,000 population) across health planning areas for
visits to rheumatologists. Analogous rates for the subset of
patients with inﬂammatory arthritis were 11.5 per 1,000
population with visits to all physicians and 6.9 per 1,000
population (68,000 patients) with visits to a rheumatologist, with a 7-fold variation by health planning area (from
1.8 to 14.8 per 1,000 population) (Table 1). Visits to rheumatologists for inﬂammatory arthritis represented 60.0%
of visits to all physicians for these conditions. The median
number of visits to PCPs for musculoskeletal disorders,

Access to Rheumatologists

235

Figure 3. Rate of visits to rheumatologists, primary care physicians (PCPs), and other
physicians for inﬂammatory arthritis, by quintiles of area socioeconomic status (SES),
Ontario: ﬁscal year 2007–2008.

our indicator of PCP access, was 250.4 per 1,000, with a
4-fold variation across health planning areas. The median
geographic availability index of rheumatologists was
highly skewed: 11 of the 105 health planning areas had no
availability, and the availability index in the remaining
areas ranged up to 521.1 per 1,000,000 population. Figure
2 shows that the highest availability was in the southern
part of the province and in the cities with medical schools.
The median distance to a rheumatologist was 44.7 km, up
to a maximum of 584 km. Nevertheless, 75% of the population lived within 50 km of the nearest rheumatologist.
Table 2 shows the rates of visits per 1,000 population to
all physicians and to rheumatologists for all arthritis and
for inﬂammatory arthritis. The rates for all arthritis and for
inﬂammatory arthritis were higher for women than men
and increased with increasing age until the age 65–74
years group. The data for the area-level indicators illustrate the variability in visits rates. In addition, Figure 3
shows the rates of visits for inﬂammatory arthritis by physician type. The results suggest that the rate of visits to
rheumatologists was highest in areas in the highest quintile of SES, with the opposite trend for PCP access, where
more patients in the lowest quintile areas were seen by
PCPs rather than rheumatologists. Only a small proportion
of patients saw other types of physicians.
Table 3 displays the results of the Poisson regressions
for the ofﬁce visits to rheumatologists for all arthritis and
inﬂammatory arthritis. After adjustments for age and an
age–sex interaction, there was a positive association between the geographic availability of rheumatologists with
visit rates for all arthritis, which was reduced after controlling for access to PCPs and SES. There was no association between geographic availability of rheumatologists

and visits for inﬂammatory arthritis. Access to PCPs and
area-level SES were signiﬁcantly associated with the visit
rates for all arthritis and inﬂammatory arthritis. There
were no signiﬁcant associations with the proportion of
the population age ⬎65 years or the proportion of rural
population.

DISCUSSION
This multilevel study examining the geographic variation
of patterns of care for arthritis across health planning areas
in Ontario, Canada showed no relationship between an
index of availability of rheumatologists with visits to rheumatologists for inﬂammatory arthritis, and only a small
effect for visits for all arthritis. However, the ﬁndings do
suggest that living in areas with low access to PCPs and
low SES is associated with a lower likelihood of having a
rheumatologist visit for both all arthritis and inﬂammatory
arthritis. This may imply difﬁculty accessing timely and
appropriate referral and treatment. It is also of concern as
the expectation is that the prevalence of arthritis should be
higher in areas of low SES (18).
The index of geographic availability of rheumatologists
used in this study is novel. It combines the amount of
service available with the distance between rheumatologists and population locations, under the assumption that
the closer the medical services, the easier it is to access
them. This measure is an improvement over traditional
physician:population ratios since it incorporates travel
distances. The use of ofﬁce hours per week of service
provision is more accurate than full-time equivalents, as it
excludes time spent in teaching, administration, and re-
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Table 3. Multilevel Poisson regression models for the rate of ofﬁce visits to rheumatologists for inﬂammatory arthritis and all
arthritis: rate ratios (RRs) and 95% conﬁdence intervals (95% CIs) for the main and adjusted effects of geographic availability
of rheumatologists, access to PCP, and SES; Ontario, ﬁscal year 2007– 08*
RR (95% CI) for
arthritis ofﬁce visits

Geographic availability of
rheumatologists
None
Quartile I
Quartile II
Quartile III
Quartile IV (highest)
Access to PCP
Quintile I (lowest)
Quintile II
Quintile III
Quintile IV
Quintile V (highest)
SES
Quintile I (lowest)
Quintile II
Quintile III
Quintile IV
Quintile V (highest)

RR (95% CI) for inﬂammatory
arthritis ofﬁce visits

Main effect
models

Adjusted model,
model 2

Main effect
models

Adjusted model,
model 2

1.00
1.08 (0.90–1.28)
1.40 (1.17–1.67)†
1.14 (1.01–1.39)†
1.30 (1.05–1.61)†

1.00
0.98 (0.84–1.14)
1.10 (0.98–1.37)
1.02 (0.86–1.23)
1.17 (1.01–1.41)†

1.00
0.96 (0.80–1.14)
1.16 (0.97–1.40)
0.88 (0.72–1.08)
1.06 (0.86–1.32)

1.00
0.91 (0.77–1.08)
1.09 (0.91–1.32)
0.87 (0.71–1.06)
1.05 (0.85–1.29)

1.00
1.06 (0.90–1.25)
1.22 (1.02–1.45)†
1.31 (1.11–1.56)†
1.53 (1.27–1.85)†

1.00
1.06 (0.91–1.22)
1.10 (0.94–1.29)
1.30 (1.12–1.52)†
1.41 (1.20–1.66)†

1.00
1.03 (0.87–1.21)
1.11 (0.93–1.32)
1.33 (1.12–1.58)†
1.27 (1.05–1.53)†

1.00
1.06 (0.90–1.24)
1.03 (0.87–1.23)
1.28 (1.08–1.52)†
1.21 (1.01–1.46)†

1.00
1.08 (0.91–1.28)
1.20 (1.01–1.42)†
1.31 (1.09–1.57)†
1.47 (1.22–1.76)†

1.00
1.06 (0.90–1.24)
1.16 (1.00–1.36)†
1.32 (1.12–1.57)†
1.40 (1.19–1.65)†

1.00
1.01 (0.84–1.21)
1.11 (0.93–1.33)
1.21 (1.00–1.46)†
1.30 (1.07–1.57)†

1.00
1.03 (0.87–1.23)
1.14 (0.96–1.35)
1.30 (1.08–1.57)†
1.30 (1.08–1.56)†

* All models include age, sex, age and sex interaction, percent population age ⱖ65 years, and percentage of rural population. PCP ⫽ primary care
physician; SES ⫽ socioeconomic status.
† Signiﬁcant at P ⬍ 0.05.

search. The index also smooths the distribution of rheumatologist availability, and gives a more realistic measure
of coverage, particularly for areas with no rheumatologists
that are adjacent to areas of more abundant provision.
We found a large area variation in geographic availability of rheumatologists, with a clustering of provision in
more populated areas, which is similar to a recent paper
on the distribution of rheumatologists in the US (28). This
American paper suggested that patients with arthritis living in areas with no or few practicing rheumatologists are
likely to have limited access to care. Our ﬁndings showed
that availability of rheumatology services may not be the
only barrier in accessing appropriate care, particularly for
inﬂammatory arthritis. In our study, the visit rates for
arthritis were associated mainly with area-level SES and
access to PCPs. It could be that rheumatologists tend to be
in areas with higher SES and to be co-distributed with
PCPs. However, this would not fully account for our ﬁndings, as in our main effect models the availability of rheumatologists was not associated with the rate of visits for
inﬂammatory arthritis, although there was a moderate relationship for all arthritis.
Our ﬁndings may also be instructive for attempts to
determine the need for rheumatologist services. Studies to
calculate the need for rheumatologists in the US have
assumed that the need is proportionate to the age and sex
distribution of conditions likely to be managed by rheumatologists, taking into account the demographics of the
current workforce (11). In addition, our study suggests that
the socioeconomic situation of local areas needs to be

taken into account when estimating rheumatologists’
needs. Furthermore, in places where specialists are only
seen by referral from another physician, a situation that is
also becoming increasingly frequent in the US, the availability of referring physicians may also need to be taken
into account.
On ﬁrst sight it seems to be a positive ﬁnding that the
index of geographic availability of rheumatologists was
associated with visits for all arthritis. However, this raises
questions about where patients with arthritis, other than
inﬂammatory arthritis, can turn to for specialist care in
areas where rheumatologists are not available. That there
was no association of rheumatologists’ availability with
visits for inﬂammatory arthritis concurs with the ﬁndings
of a study from Quebec, Canada (17). The ﬁndings suggest
that, once referred, rheumatologists give preference to inﬂammatory arthritis patients, i.e., patients with other
forms of arthritis are likely to be seen only in those areas
where there is adequate availability of rheumatologists.
This ﬁts with studies of wait times that have conﬁrmed
that rheumatologists tend to prioritize inﬂammatory arthritis patients (29,30). The lack of association between
rheumatologist availability and visits for inﬂammatory arthritis may also be a sign that there is a systemic underprovision in all areas.
The ﬁnding that less than two-thirds of all inﬂammatory
arthritis visits were to rheumatologists is similar to that
from other population-based studies (6,7). The proportion
varied somewhat by area characteristics: the highest proportion visiting a rheumatologist was 67% in areas of high
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SES. As shown in Figure 3, patients with visits for inﬂammatory arthritis and not seeing a rheumatologist were
likely to see PCPs, particularly in low SES areas. This is
concerning, since patients without ready access to rheumatology tend to have worse outcomes (31) and, as indicated in the Introduction, inﬂammatory arthritis patients
treated by PCPs are less likely to be treated with DMARDs
(4 –7).
The few studies that have examined the effect of SES on
access to rheumatologists in the population are consistent
in suggesting access barriers for low SES individuals. A
population-based study using administrative data showed
longer delays in consultation with a rheumatologist for
those living in low versus higher SES areas (32), and a
clinical study of RA patients found that those with low
SES made signiﬁcantly less use of specialist care (33).
Furthermore, studies of patients with systemic lupus erythematosus have found that patients with low SES were
less likely to visit rheumatologists (34,35). The literature is
also consistent in showing that low SES patients with
inﬂammatory arthritis have worse outcomes than those
with higher SES (36 –38). These inequalities by SES may
be a reﬂection of higher demand by high SES patients or
may indicate barriers to access to care, including travel
distances, costs, loss of wages (39), and low health literacy
(40).
The inverse association between visit rates to rheumatologists for inﬂammatory arthritis and access to PCPs
suggests that patients who do not have access to PCPs are
less likely to be referred. While this seems to be common
sense, it does suggest a need for other arrangements to
identify and refer patients. Strategies to encourage early
referral for inﬂammatory arthritis have largely focused on
triage of referrals and on the need for education of PCPs
(3). These approaches may need to be broadened to develop strategies to reach potential patients who may not
have easy access to PCPs for assessment and referral.
These tend to be in more rural areas that may not be able
to support a full-time rheumatologist. In Ontario, some
rheumatologists travel to rural locations on an occasional
basis and the use of telemedicine is increasing.
A further solution is the use of other practitioners. Primary health care reform in Ontario is promoting interprofessional health care teams and nurse practitioners providing care, particularly in areas of doctor shortages (41). This
needs to be supported by arthritis-related interprofessional
education (42). In Ontario, the Advanced Clinician Practitioner in Arthritis Care program is a training program for
experienced physical therapists, occupational therapists,
and nurses to assume roles of triage, education, and, in
selected cases, management of patients with osteoarthritis
and inﬂammatory arthritis (43). Evaluation of this program
has shown reduced wait times and indicated potential to
provide access to arthritis care in areas where there are
severe shortages of specialized arthritis care physicians
(43). Although an encouraging ﬁnding, sustainable funding will continue to be a potential barrier for the wider
implementation of such programs.
A major advantage of our study is the comprehensive
coverage of the Ontario publicly funded health care system, which covers all medically necessary physician vis-
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its, without the impacts of insurance coverage on access to
care seen in the US. This permitted us to look at the
inﬂuence of ecological variables, such as per capita provision of rheumatology and PCP services on rheumatology
visits. Furthermore, we were also able to examine the
source of inequities in rheumatologist visit rates by further
incorporating an area-based measure of SES. Our measure
of availability of rheumatologists has the advantage of
incorporating the number of hours of clinical service provided per week. However, we had no information about
whether rheumatologists were accepting new patients or
not, nor do we know anything about quality of care. The
lack of association with rheumatologist availability does
not rule out the fact that patients living in areas of low
availability could be referred to other areas. Indeed, many
of the areas of low availability are in the northern, sparsely
populated part of Ontario where there are governmentprovided travel grants that fund patients to travel to receive services elsewhere.
Our study’s limitations are those inherent to ecological
studies and the use of health service data, including lack of
individual data on variables associated with need for
health care such as SES. We also have no information on
patients in need of care who did not visit any physicians
for their arthritis. The focus on variation between health
planning regions may obscure large variations for individuals living within those regions. The deﬁnition of inﬂammatory arthritis was at least 1 visit to a physician; there is
likely to be some diagnostic uncertainty and, in particular,
inﬂammatory arthritis may be incorrectly classiﬁed by
PCPs. Nevertheless, the overall prevalence for inﬂammatory arthritis, likely mainly rheumatoid arthritis, based on
1 visit, is 11.5 per 1,000 (Table 1), which is similar to a
conservative population prevalence of approximately 1%,
with the expected female preponderance and age proﬁle
(44). A further limitation is that we did not have the
number of practicing PCPs and had to rely on a measure of
utilization as a proxy for access. Differences in utilization
rates may reﬂect not only variation in the number of available physicians but differences in the ability and preferences of physicians in managing common musculoskeletal
disorders (5).
This is one of the few studies that examine variations
in visits to rheumatologist services at the population level.
Using area-based data on rheumatologist services for arthritis, this study provides some insights into the complexity of factors that impact how patients access rheumatology care. This study shows that patients with
inﬂammatory arthritis living in areas of low SES or with a
low provision of primary care services were less likely to
see a rheumatologist. Models of care that incorporate primary health care resources, as well as the location and
amount of rheumatology services, are crucial to improve
access to care for people with all types of arthritis, particularly in areas of low SES. Nonetheless, our results point
to the importance of considering factors related to access
to PCPs to ensure adequate access to rheumatology services in the population, especially when access to specialty care requires primary care referral.
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